Literature DB >> 28208842

Assessment of Serum VASPIN Levels among Type 2 Diabetes Mellitus Patients with or without Acute Coronary Syndrome.

Aswathy Jaya Sathyaseelan1, Prashant Shankarrao Adole2, Mukta Wyawahare3, Rama Prakasha Saya4.   

Abstract

INTRODUCTION: Type 2 Diabetes Mellitus (DM) is on the verge of becoming a pandemic in India. Type 2 DM patient have two to four times increased risk of carotid artery disease. Adipokines have been regarded recently as direct link between diabetes and atherosclerosis. Visceral Adipose Tissue Derived Serine Protease Inhibitor (VASPIN); one of the most recently discovered adipokine, inhibits the proteases responsible for insulin resistance, carotid plaque development and rupture. In literature, few studies have addressed the role of VASPIN in pathogenesis of Acute Coronary Syndrome (ACS) in patients with type 2 DM. AIM: To find association between serum VASPIN with lipid profile, creatine kinase-total, creatine kinase-MB, troponin-I, age, height, weight, blood pressure, smoking, family history of ACS and to prove the hypothesis of low serum VASPIN level as predictor of ACS in patients with type 2 DM.
MATERIALS AND METHODS: Forty-one type 2 DM patients (controls) and 41 type 2 DM patients with ACS (cases) were enrolled in the study. Anthropometric measurements were performed and fasting serum biochemical parameters and VASPIN were measured. The results of cases and controls were compared by student t-test or Mann-Whitney test. All the parameters were correlated with serum VASPIN by Pearson's or Spearman's correlation.
RESULTS: Fasting serum VASPIN concentration was significantly (p< 0.0001) lower in the cases (0.43±0.22 pg/ml) than in the controls (0.83±0.29 pg/ml). Correlation analysis undertaken on all type 2 DM showed that serum VASPIN concentration was negatively correlated with age, waist circumference, hip circumference, systolic and diastolic blood pressure, duration of diabetes, serum Creative Kinase-Total, CK-MB and urea (p< 0.05). Utilizing Receiver Operating Characteristic (ROC) curve, the serum VASPIN level of less than 0.594pg/ml showed greatest risk of ACS among type 2 DM patients (p< 0.0001).
CONCLUSION: Type 2 DM patients with low serum vaspin concentration were at risk of ACS independent of other cardiovascular risk factors.

Entities:  

Keywords:  Adipokines; Coronary artery disease; Diabetic patients

Year:  2016        PMID: 28208842      PMCID: PMC5296415          DOI: 10.7860/JCDR/2016/22417.8952

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  28 in total

1.  ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.

Authors:  Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Jonathan L Halperin; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2007-08-06       Impact factor: 29.690

2.  The current state of diabetes mellitus in India.

Authors:  Seema Abhijeet Kaveeshwar; Jon Cornwall
Journal:  Australas Med J       Date:  2014-01-31

3.  Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.

Authors:  Baowei Zhang; Wenhui Peng; Hailing Li; Yuyan Lu; Jianhui Zhuang; Ke Wang; Yang Su; Yawei Xu
Journal:  Clin Biochem       Date:  2013-07-11       Impact factor: 3.281

Review 4.  Epidemiology of cardiovascular disease in type 2 diabetes: the Indian scenario.

Authors:  Viswanathan Mohan; Janarthanan Vijay Venkatraman; Rajendra Pradeepa
Journal:  J Diabetes Sci Technol       Date:  2010-01-01

5.  Serum vaspin levels in type 2 diabetic women in relation to microvascular complications.

Authors:  Nese Ersoz Gulcelik; Jale Karakaya; Arzu Gedik; Aydan Usman; Alper Gurlek
Journal:  Eur J Endocrinol       Date:  2008-10-24       Impact factor: 6.664

6.  Vaspin serum concentration in patients with type 2 diabetes and carotid plaque.

Authors:  Z Li; C Ma; L Li; X Pan; L Chen
Journal:  J Int Med Res       Date:  2012       Impact factor: 1.671

7.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

8.  The investigation of serum vaspin level in atherosclerotic coronary artery disease.

Authors:  Mehmet Ali Kobat; Ahmet Celik; Mehmet Balin; Yakup Altas; Adil Baydas; Musa Bulut; Suleyman Aydin; Necati Dagli; Mustafa Ferzeyn Yavuzkir; Selcuk Ilhan
Journal:  J Clin Med Res       Date:  2012-03-23

Review 9.  Coronary Microvascular Function and Beyond: The Crosstalk between Hormones, Cytokines, and Neurotransmitters.

Authors:  Carlo Dal Lin; Francesco Tona; Elena Osto
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

10.  Role of serum vaspin in progression of type 2 diabetes: a 2-year cohort study.

Authors:  Weixia Jian; Wenhui Peng; Sumei Xiao; Hailing Li; Jie Jin; Li Qin; Yan Dong; Qing Su
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

View more
  8 in total

1.  Altered expression of a disintegrin and metalloproteinase 10 in peripheral blood mononuclear cells in type 2 diabetes mellitus patients with the acute coronary syndrome: a pilot study.

Authors:  Ravindran Ragavi; Prashant Shankarrao Adole; Kolar Vishwanath Vinod; Ajith Ananthakrishna Pillai
Journal:  Endocrine       Date:  2022-07-25       Impact factor: 3.925

2.  Decreased levels of vaspin and its potential association with cardiometabolic risk in patients with psoriasis: preliminary results.

Authors:  Paulina Kiluk; Anna Baran; Tomasz W Kaminski; Magdalena Maciaszek; Iwona Flisiak
Journal:  Postepy Dermatol Alergol       Date:  2021-02-07       Impact factor: 1.664

3.  Assessment of serum tenascin-C and growth differentiation factor-15 among type 2 diabetes mellitus patients with and without acute coronary syndrome.

Authors:  Murugaiyan Vasanthi; Prashant Shankarrao Adole; Vinay Ramakrishna Pandit; Kolar Vishwanath Vinod
Journal:  J Med Biochem       Date:  2020-10-02       Impact factor: 3.402

4.  Elevated serum IL-6 and adiponectin levels are associated with frailty and physical function in Chinese older adults.

Authors:  Lina Ma; Guiming Sha; Yaxin Zhang; Yun Li
Journal:  Clin Interv Aging       Date:  2018-10-15       Impact factor: 4.458

5.  Association of vaspin rs2236242 gene polymorphism with serum vaspin level, insulin resistance and diabetes in an Iranian diabetic/pre-diabetic population.

Authors:  Maria Hosseini; Masoumeh Nezhadali; Mehdi Hedayati
Journal:  J Med Biochem       Date:  2021-01-26       Impact factor: 3.402

6.  Correlation of Serum Vaspin, Omentin-1, and adiponectin with metabolic phenotypes in Type-2 diabetes mellitus patients.

Authors:  Mukhtiar Baig; Zohair J Gazzaz; Marwan A Bakarman; Sami H Alzahrani
Journal:  Pak J Med Sci       Date:  2021 Nov-Dec       Impact factor: 1.088

7.  Rosuvastatin Improves Vaspin Serum Levels in Obese Patients with Acute Coronary Syndrome.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; Ali K Al-Buhadilly
Journal:  Diseases       Date:  2018-01-16

8.  Anti-Atherogenic Effects of Vaspin on Human Aortic Smooth Muscle Cell/Macrophage Responses and Hyperlipidemic Mouse Plaque Phenotype.

Authors:  Kengo Sato; Remina Shirai; Maho Yamaguchi; Tomoyuki Yamashita; Koichiro Shibata; Taisuke Okano; Yusaku Mori; Taka-Aki Matsuyama; Hatsue Ishibashi-Ueda; Tsutomu Hirano; Takuya Watanabe
Journal:  Int J Mol Sci       Date:  2018-06-11       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.